Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
3
目的:探讨我院急性非淋巴细胞性白血病(ANLL)患者的治疗效果及其预后相关因素。
Objective: to investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.